In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

AGORACOM News Flash

MARKET PRESSURE = BUYING OPPORTUNITIES

As predicted on the AGORACOM Blog, it appears we are now moving into capitulation phase and a great opportunity to buy good small-caps that have been thrown out with the bathwater. 

Follow AGORACOM commentary on:

  George's Blog    Grandich Blog

AGORACOM Micro-Blog

AlphaRx > Message
Generic_profile

Re: Zysolin boosts survival in animal pneumonia model

Posted by: drummer on July 07, 2008 02:50PM

In response to: Zysolin boosts survival in ... by Tutty

thanks for posting the content, tutty!! It's good to see the attention alpha is getting. More than 1.2 million Americans – roughly equivalent to the population of Dallas – were hospitalized for pneumonia in 2006, making this lung infection the most common reason for admission to the hospital other than for childbirth, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

Post a Reply

Please login to reply to this message.

Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote